Wikidata

(Q45108224)

English

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster

scientific article published on 14 October 2004

In more languages

Statements

title
Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
author name string
Gary F Lewis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
Kristine Uffelman
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
Mark Naples
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
Linda Szeto
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
Mehran Haidari
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
Khosrow Adeli
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
publication date
14 October 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017
page(s)
247-255
1 reference
stated in
Europe PubMed Central
PubMed ID
15486228
retrieved
9 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45108224&oldid=2066215679"